Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating expenses:
Research and development expenses	$ 22,565,524	$ 27,762,784
General and administrative expenses	13,755,671	15,282,450
Total operating expenses	36,321,195	43,045,234
Loss from operations	(36,321,195)	(43,045,234)
Interest income (expense), net
Interest income	2,514,816	2,902,939
Interest expense	(4,673,174)	(4,205,922)
Interest income (expenses), net	(2,158,358)	(1,302,983)
Loss before income taxes	(38,479,553)	(44,348,217)
Benefit from income taxes	869,169	1,406,019
Net loss	(37,610,384)	(42,942,198)
Comprehensive loss	$ (37,610,384)	$ (42,942,198)
Per share information:
Net loss per share, basic (in dollars per share)	$ (1.03)	$ (1.39)
Net loss per share, diluted (in dollars per share)	$ (1.03)	$ (1.39)
Weighted average common shares outstanding, basic (in shares)	36,452,707	30,952,060
Weighted average common shares outstanding, diluted (in shares)	36,452,707	30,952,060